Track the Capnia, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 9 February 2016 (J). Among the most active insiders: ENGLEMAN EDGAR. The full history is free.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Capnia, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental score
Ranked 27,722 of 28,803 companies
13.8
score / 100
Value
23
Quality
4
FCF yld-4.0%
Earn yld-5.0%
EV/EBITDA·
ROE-40%
Gross mgn-0.0%
Net mgn-68%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Capnia, Inc. is a company focused on developing technologies for the diagnosis and treatment of respiratory diseases. It is listed on NASDAQ under the ticker XNAS.